AzTrials
AzTrials

FrailtyICOPE 29NCT05541731

Implementation Study of the ICOPE Program for the Detection of Frailty in the Elderly Within the Territorial Health Professional Communities (CPTS) of Brest Region

An observational study of Frailty, run by University Hospital, Brest at 2 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Frailty is a geriatric syndrome resulting from a decrease in physiological reserve capacities altering the mechanisms of adaptation to stress with, in the absence of diagnosis and management, a short-term risk of falls, hospitalization, loss of autonomy and death. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Frailty
How many people
56 participants
Where
2 sitesFrance
Study dates
19 Jan 2023to 19 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: All primary care staff in the two CPTS caring for non-dependent patients aged 70 and over

Who may be able to join

  • Primary care staff belonging to one of the 2 CPTS (CPTS Brest Santé Océane and CPTS Iroise santé) and having accepted to participate in the study

Who cannot join

  • Refusal to participate in the study

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Cpts Brest Sante Oceane

    Guipavas

  • Cpts Pays D'Iroise

    Saint-Renan

Other trials in France

About this study

Frailty is a geriatric syndrome resulting from a decrease in physiological reserve capacities altering the mechanisms of adaptation to stress with, in the absence of diagnosis and management, a short-term risk of falls, hospitalization, loss of autonomy and death.

In 2019, the World Health Organization has taken up this subject with the objective of reducing the number of dependent people in the world by 15 million, i.e. 150,000 in France. For this purpose, recommendations for integrated care for seniors (Integrated Care for Older People = ICOPE) have been published.

Read more

6 functions are essential to maintain autonomy: mobility, memory, sight, hearing, mental health and nutrition. The first step of the ICOPE program consists of screening for a decline in one of these functions using a tool made up of questions or tests that can be carried out in 8 to 10 minutes in primary care by trained non-professionals. The second step is a thorough evaluation of the person screened, leading to the creation of a personalized care plan. In the current state of affairs, despite its recommendations, this identification is not carried out in Brittany.

The objective of this study is to demonstrate the feasibility of implementing the first stage of the ICOPE program by seizing the opportunity of the creation in the Brest region of two Territorial Health Professional Communities (CPTS) : Brest Santé Océane and Iroise santé.

Conditions
Frailty
Medical subject headings
Frailty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of identifying frail elderly people aged 70 and over

    Number of patients screened using the ICOPE (Integrated Care for Older People) program by the primary care professionals of the CPTS Brest Santé Océane and Iroise santé, one in an urban environment and the other in a semi-rural environment.

    To demonstrate the feasibility of identifying frail elderly people aged 70 and over, using the ICOPE program, by health professionals working in two CPTSs, Brest Santé Océane and Iroise santé, .

    Measured: Month 12

Secondary outcomes (2)
  1. Rate of individuals who had one or more of the 6 essential functions for maintaining independence

    Calculate the rate of individuals who had one or more of the 6 identified as impaired by the use of the ICOPE program in these two territories.

    Number of patients for whom one or more of the 6 functions (mobility, memory, sight, hearing, mental health and nutrition) essential for maintaining autonomy is impaired using the ICOPE MONITOR application. This developed by the Gerontopôle of the Toulouse University Hospital, allows the measurement of the capacities necessary for the prevention of dependency in a few minutes. This application can be downloaded free of charge for health professionals, on a smartphone or tablet.

    The assessment of the ICOPE MONITOR application consists of a series of 9 questions, an auditory examination (whisper test) and a chair rise test (have the patient rise from a chair with arms crossed over the chest 5 times in a row as quickly as possible). This assessment identifies whether the patient has any of the 6 impaired functions.

    Measured: Month 12

  2. Feeling about the ICOPE MONITOR tool

    Perception of the ICOPE MONITOR tool by professionals (qualitative study using semi-structured interviews and group interviews). There are no score.

    Measured: Month 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2022
  2. Study start19 Jan 2023
  3. Primary completion5 Jun 2023
  4. Study completion19 Apr 2024

Why it stopped: Coordinator decision

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05541731
Sponsor's protocol ID
29BRC22.0102
Acronym
ICOPE 29
Status last verified
Apr 2024
First submitted
13 Sep 2022
Last updated
26 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Publications

  • Pellen N, Beurton-Couraud L, Goff-Coquet AL, Tramecon A, Gentric A, Le Reste JY. Five reasons for the failure of frailty screening in primary care: lessons from the experience with ICOPE monitor step 1. BMC Geriatr. 2025 Nov 26;25(1):1059. doi: 10.1186/s12877-025-06789-6.

    PubMed 41299329

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty, run by University Hospital, Brest at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Coordinator decision). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of identifying frail elderly people aged 70 and over (time frame: Month 12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05541731, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in